MARCENARO, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 19.862
AS - Asia 777
SA - Sud America 113
NA - Nord America 95
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.868
Nazione #
IT - Italia 19.838
SG - Singapore 315
CN - Cina 248
VN - Vietnam 154
BR - Brasile 73
US - Stati Uniti d'America 73
AR - Argentina 21
HK - Hong Kong 20
MX - Messico 18
IQ - Iraq 9
BD - Bangladesh 7
EC - Ecuador 7
ID - Indonesia 7
NL - Olanda 4
RU - Federazione Russa 4
VE - Venezuela 4
ZA - Sudafrica 4
BG - Bulgaria 3
CL - Cile 3
DZ - Algeria 3
IN - India 3
PE - Perù 3
CR - Costa Rica 2
EG - Egitto 2
ES - Italia 2
GB - Regno Unito 2
MA - Marocco 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AO - Angola 1
AT - Austria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
DJ - Gibuti 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TR - Turchia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.868
Città #
Genova 11.514
Genoa 5.162
Rapallo 1.653
Vado Ligure 1.437
Singapore 145
Beijing 73
Ho Chi Minh City 62
Bordighera 51
Hanoi 39
Ashburn 33
Hong Kong 20
Mexico City 12
Tianjin 12
Haiphong 11
Da Nang 7
Rome 7
São Paulo 6
Los Angeles 5
New York 5
Brasília 4
Council Bluffs 4
Guayaquil 4
Orem 4
Baghdad 3
Biên Hòa 3
Chieti 3
Hải Dương 3
San Jose 3
Agadir 2
Algiers 2
Amsterdam 2
As Samawah 2
Barcelona 2
Brooklyn 2
Buenos Aires 2
Can Tho 2
Dallas 2
Dhaka 2
Formosa 2
Johannesburg 2
Karachi 2
Maringá 2
Milan 2
Ninh Bình 2
Osasco 2
Phoenix 2
Phúc Yên 2
Rio de Janeiro 2
Rondonópolis 2
Rosario 2
Salta 2
San José 2
Santa Clara 2
Thái Bình 2
Addis Ababa 1
Albuzzano 1
Alvorada 1
Amman 1
Ankara 1
Anyang 1
Araguari 1
Arequipa 1
Bahía Blanca 1
Balsas 1
Bandung 1
Baoding 1
Barquisimeto 1
Basra 1
Benito Juarez 1
Berazategui 1
Boituva 1
Bologna 1
Bom Jardim 1
Boston 1
Brazzaville 1
Bryansk 1
Bukhara 1
Butiá 1
Bắc Ninh 1
Cairo 1
Caldas Novas 1
Campina Grande 1
Cao Lanh 1
Caracas 1
Cariacica 1
Casilda 1
Caxias do Sul 1
Chengdu 1
Chicago 1
Chisinau 1
Cochagual 1
Coimbra 1
Comodoro Rivadavia 1
Coronel Brandsen 1
Cuenca 1
Curitiba 1
Curvelo 1
Cássia 1
Davao City 1
Denver 1
Totale 20.383
Nome #
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 198
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 197
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 194
2B4 functions as a co-receptor in human NK cell activation 190
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 186
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 182
Features of Memory-Like and PD-1+ Human NK Cell Subsets 182
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 179
Bridging innate NK cell Functions with Adaptive Immunity. 178
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. 176
NK/DC crosstalk in anti-viral response. 176
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 174
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 173
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 170
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 166
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 165
NK cells and their receptors during viral infections. 164
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 162
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 162
Markers and function of human NK cells in normal and pathological conditions 161
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 158
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 158
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components 157
Multi-directional cross-regulation of NK cell function during innate immune responses. 156
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 155
Harnessing NK Cells for Cancer Treatment 155
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 151
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 150
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation 150
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 150
Human NK cell response to pathogens 149
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 149
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 149
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 146
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 146
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways 143
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 143
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 142
Natural killer lymphocytes: "null cells" no more. 142
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 140
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 139
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 139
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 137
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 137
It's only innate immunity but I like it 137
Pathogen-induced private conversations between natural killer and dendritic cells 135
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 134
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 134
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment 134
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 133
TLR/NCR/KIR: Which One to Use and When? 133
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 132
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 132
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. 131
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 131
Natural killer cell-triggering receptors in patients with acute leukaemia. 131
Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pigtailed monkeys 130
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues 129
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 129
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 129
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 128
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 128
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 127
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 126
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 126
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 125
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 125
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis 124
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 122
IL-12 or IL-4 prime human Natural Killer cells to mediate functionally divergent interactions with Dendritic cells or tumors 121
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 121
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 121
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer cell subsets associated with high levels of HIV-1 viremia. 120
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 120
NK cells: innate immunity against hematological malignancies? 120
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 119
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 119
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 117
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 117
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. 117
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 117
IL-12 or IL-4 prime human natural killer cells to mediate functionally divergent interactions with dendritic cells or tumors 116
Adaptor protein 3 complex deficiency causes innate immunity defects 116
NK-DC interaction: On the usefulness of auto-aggression 114
IL-12 or IL-4 prime human Natural Killer Cells to mediate functionally diverent interactions with dendritic cells or tumors 114
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 114
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 113
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 113
Editorial: NK Cell Subsets in Health and Disease: New Developments 113
The NK/DC complot 112
Natural killer cells in HIV-Infectious: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. 111
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 111
NK Cell-Based Immunotherapy in Colorectal Cancer 110
Monoclonal Antibodies against NKG2A 110
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 110
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 110
Human Natural Killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection 109
Cognate HLA absence in trans diminishes human NK cell education 109
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 109
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection 108
Totale 13.872
Categoria #
all - tutte 71.413
article - articoli 55.270
book - libri 602
conference - conferenze 8.037
curatela - curatele 0
other - altro 461
patent - brevetti 4.848
selected - selezionate 0
volume - volumi 2.195
Totale 142.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021966 0 0 0 0 0 233 44 113 119 217 105 135
2021/20222.122 77 160 151 183 116 118 142 495 156 186 95 243
2022/20232.047 238 154 23 194 297 348 4 178 381 21 178 31
2023/20241.164 63 177 34 136 93 122 80 125 69 48 80 137
2024/20253.516 76 260 133 229 511 337 363 501 117 191 375 423
2025/20262.685 706 177 420 479 766 137 0 0 0 0 0 0
Totale 21.358